|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||30.25 - 30.25|
|52-week range||30.25 - 30.25|
|Beta (5Y monthly)||1.31|
|PE ratio (TTM)||0.23|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Prothena (PRTA) incurs a loss in the second quarter while revenues miss estimates.
Prothena (PRTA) delivered earnings and revenue surprises of -72.55% and 93.48%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...